Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on August 22, 2002; DOI 10.1182/blood-2002-06-1732.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-06-1732v1
101/2/624    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tonks, A.
Right arrow Articles by Darley, R. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tonks, A.
Right arrow Articles by Darley, R. L
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted June 12, 2002
Accepted August 12, 2002

The AML1-ETO fusion gene promotes extensive self-renewal of human primary erythroid cells

Alex Tonks*, Lorna Pearn, Amanda J Tonks, Laurence Pearce, Terry Hoy, Sarah Phillips, Janet Fisher, James R Downing, Alan K Burnett, and Richard L Darley

Department of Haematology, University of Wales College of Medicine, Cardiff, United Kingdom
Department of Pathology, St Jude Children's Research Hospital, Memphis, TN, USA

* Corresponding author; email: tonksa{at}cf.ac.uk.

The t(8;21) translocation which encodes the AML1-ETO fusion protein (now known as RUNX1-CBF2T1), is one of the most frequent translocations in acute myeloid leukaemia, though its role in leukaemogenesis is unclear. Here, we report that exogenous expression of AML1-ETO in human CD34+ cells severely disrupts normal erythropoiesis resulting in virtual abrogation of erythroid colony formation. In contrast, in bulk liquid culture of purified erythroid cells, we found that during early (erythropoietin-independent) erythropoiesis, though AML1-ETO initially inhibited proliferation, growth inhibition gave way to a sustained EPO-independent expansion of early erythroid cells that continued for more than 60 days, whereas control cultures became growth arrested after 10-13 days (at the EPO-dependent stage of development). Phenotypic analysis showed that while these cells were CD13-, CD34-, unlike control cultures, these cells failed to up-regulate CD36 or to down-regulate CD33 suggesting that expression of AML1-ETO suppressed the differentiation of these cells and allowed extensive self-renewal to take place. In the early stages of this expansion, addition of EPO was able to promote both phenotypic (CD36+, CD33-, glycophorin A+) and morphological differentiation of these cells, almost as effectively as in control cultures. However, with extended culture, cells expressing AML1-ETO became refractory to addition of this cytokine suggesting that a block in differentiation had been established. These data demonstrate the capacity of AML1-ETO to promote the self-renewal of human haematopoietic cells and therefore support a causal role for t(8;21) translocations in leukaemogenesis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
O. Krejci, M. Wunderlich, H. Geiger, F.-S. Chou, D. Schleimer, M. Jansen, P. R. Andreassen, and J. C. Mulloy
p53 signaling in response to increased DNA damage sensitizes AML1-ETO cells to stress-induced death
Blood, February 15, 2008; 111(4): 2190 - 2199.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Wunderlich, O. Krejci, J. Wei, and J. C. Mulloy
Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability
Blood, September 1, 2006; 108(5): 1690 - 1697.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Takeda, C. Goolsby, and N. R. Yaseen
NUP98-HOXA9 Induces Long-term Proliferation and Blocks Differentiation of Primary Human CD34+ Hematopoietic Cells.
Cancer Res., July 1, 2006; 66(13): 6628 - 6637.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y.-Y. Wang, G.-B. Zhou, T. Yin, B. Chen, J.-Y. Shi, W.-X. Liang, X.-L. Jin, J.-H. You, G. Yang, Z.-X. Shen, et al.
AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: Implication in stepwise leukemogenesis and response to Gleevec
PNAS, January 25, 2005; 102(4): 1104 - 1109.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Zhang, J. R. Biggs, and A. S. Kraft
Phorbol Ester Treatment of K562 Cells Regulates the Transcriptional Activity of AML1c through Phosphorylation
J. Biol. Chem., December 17, 2004; 279(51): 53116 - 53125.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Yan, S. A. Burel, L. F. Peterson, E. Kanbe, H. Iwasaki, A. Boyapati, R. Hines, K. Akashi, and D.-E. Zhang
From the Cover: Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development
PNAS, December 7, 2004; 101(49): 17186 - 17191.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Tsuzuki, M. Seto, M. Greaves, and T. Enver
Modeling first-hit functions of the t(12;21) TEL-AML1 translocation in mice
PNAS, June 1, 2004; 101(22): 8443 - 8448.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. E. Elagib, F. K. Racke, M. Mogass, R. Khetawat, L. L. Delehanty, and A. N. Goldfarb
RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation
Blood, June 1, 2003; 101(11): 4333 - 4341.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020